🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Akimitsu Yamada

Yokohama City University Medical Center

ORCID: 0000-0003-3006-0648

Also affiliated with Yokohama City University Hospital, Yokohama City University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer”.

Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00466-2

N/A

0.571DataRank · unranked

44 citations

Ankit Patel, Rongrong Wu, Lan Le, Yoshihisa Tokumaru, Akimitsu Yamada +6 more

Breast cancer in adolescents and young adults has a specific biology and poor patient outcome compared with older patients

ESMO Open(2024)10.1016/j.esmoop.2024.103737

N/A

0.500DataRank · unranked

9 citations

Akimitsu Yamada, Sanyam Gandhi, Rui Wu, Makoto Sasamoto, Shinya Yamamoto +5 more

The clinical relevance of unfolded protein response signaling in breast cancer

Research Square(2022)10.21203/rs.3.rs-1480002/v1

N/A

0.345DataRank · unranked

9 citations

Arya Mariam Roy, Shipra Gandhi, Yoshihisa Tokumaru, Li Yan, Akimitsu Yamada +3 more

Infiltration of Common Myeloid Progenitor (CMP) Cells is Associated With Less Aggressive Tumor Biology, Lower Risk of Brain Metastasis, Better Response to Immunotherapy, and Higher Patient Survival in Breast Cancer

Annals of Surgery(2024)10.1097/sla.0000000000006428

N/A

0.292DataRank · unranked

6 citations

Rongrong Wu, Thaer Khoury, Shipra Gandhi, Yan Li, Akimitsu Yamada +4 more

Aldehyde Dehydrogenase 1-related Genes in Triple-negative Breast Cancer Investigated Using Network Analysis

Anticancer Research(2020)10.21873/anticanres.14696

N/A

0.241DataRank · unranked

4 citations

Chiho Suzuki‐Minakuchi, Hidetaka Shima, Kumiko Kida, Shoko Adachi, Shinya Yamamoto +11 more

GALNT1 Expression Is Associated with Angiogenesis and Is a Prognostic Biomarker for Breast Cancer in Adolescents and Young Adults (AYA)

Cancers(2023)10.3390/cancers15133489

N/A

0DataRank · unranked

8 citations

Danya Ziazadeh, Rongrong Wu, Kohei Chida, Akimitsu Yamada, Shinya Yamamoto +6 more

Eribulin induces micronuclei and enhances the nuclear localization of cGAS in triple-negative breast cancer cells

Research Square(2023)10.21203/rs.3.rs-3672056/v1

N/A

0DataRank · unranked

1 citations

Mamoru Takada, Dhaval Ghone, Muhan Yu, Takeshi Nagashima, Hiroshi Fujimoto +9 more

Eribulin induces micronuclei and enhances the nuclear localization of cGAS in triple-negative breast cancer cells

Scientific Reports(2024)10.1038/s41598-024-64651-y

N/A

0DataRank · unranked

5 citations

Mamoru Takada, Dhaval Ghone, Muhan Yu, Takeshi Nagashima, Hiroshi Fujimoto +9 more

Bromodomain-containing Protein 4 Is a Favourable Prognostic Factor in Breast Cancer Patients

Anticancer Research(2021)10.21873/anticanres.15148

N/A

0DataRank · unranked

1 citations

Akimitsu Yamada, Shoko Adachi, Hidetaka Shima, Kumiko Kida, Masanori Oshi +9 more

Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06633-0

N/A

0DataRank · unranked

77 citations

Shipra Gandhi, Li Yan, Yoshihisa Tokumaru, Rongrong Wu, Akimitsu Yamada +4 more

High miR-99b expression is associated with cell proliferation and worse patient outcomes in breast cancer

Research Square(2022)10.21203/rs.3.rs-1963644/v1

N/A

0DataRank · unranked

13 citations

Yoshihisa Tokumaru, Matthew G.K. Benesch, Nobuhiko Sugito, Rongrong Wu, Li Yan +6 more

Establishment of a novel BRCAness score that predicts response to PARP inhibitors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.549

N/A

0DataRank · unranked

0 citations

Shipra Gandhi, Rongrong Wu, Mariko Asaoka, Li Yan, Akimitsu Yamada +6 more